BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23661553)

  • 1. TGF-β signaling in myeloid cells is required for tumor metastasis.
    Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
    Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
    Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
    J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
    Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
    Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
    Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
    Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
    Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
    Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid TGF-β responsiveness promotes metastases.
    Souza-Fonseca-Guimaraes F; Smyth MJ
    Cancer Discov; 2013 Aug; 3(8):846-8. PubMed ID: 23928773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reciprocal role of prostate cancer on stromal DNA damage.
    Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
    Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
    Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
    Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.